Advanced Science, 2024 · DOI: 10.1002/advs.202306577 · Published: March 5, 2024
Spinal cord injuries lead to cell death and loss of motor function. Stem cell transplants are a possible treatment, but they don't always work well because the injury environment is not conducive to cell survival and growth. This study introduces a new hydrogel that contains insulin-like growth factor-1 (IGF-1). The hydrogel helps neural stem cells (NSCs) survive, grow, and turn into neurons and oligodendrocytes, which are important for nerve function. The hydrogel also encourages the growth of nerve fibers and myelin regeneration at the injury site. Additionally, it concentrates beneficial substances (EVs) that promote axon regeneration and remyelination, even in an inflammatory environment. This approach shows promise as a treatment for spinal cord injuries.
The combined use of NSCs and IGF-1 gels represents a promising therapeutic strategy for spinal cord injury.
This approach can improve neurogenesis and neurological functional recovery following SCI.
Enhancing the bioactivation of EVs derived from grafted NSCs offers a new avenue for SCI treatment.